Clinical Trial Update: Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating venetoclax combined with azacitidine for therapy-related or secondary myelodysplastic syndrome; the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Therapy-related Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Uma Borate | Conditions: Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING